Dr Berg
Dr. Berg Friendly Bacteria Probiotic Liquid: 12 Strains for Optimal Gut Health - 16.3 fl oz
Dr. Berg Friendly Bacteria Probiotic Liquid: 12 Strains for Optimal Gut Health - 16.3 fl oz
Couldn't load pickup availability
Product Overview
Dr. Berg Friendly Bacteria Probiotic Liquid delivers a 12-strain probiotic consortium in a liquid suspension that achieves ambient-temperature shelf stability without refrigeration — a clinically relevant feature in Singapore's tropical distribution environment. The formula includes both homofermentative and heterofermentative Lactobacillus species, multiple Bifidobacterium strains for large intestinal colonisation, the yeast-based Saccharomyces cerevisiae for barrier function support, and Bacillus subtilis as a resilient spore-forming probiotic with documented colonisation resistance activity against enteric pathogens.
The liquid format provides advantages over encapsulated probiotics in paediatric populations, patients with dysphagia, and those on nasogastric or PEG tube feeding protocols, as the suspension can be measured precisely and mixed into enteral feeds. Each 15 ml serving is drawn from the 500 ml bottle and contains viable organisms meeting the manufacturer-stated efficacy level (4.5 × 10⁶ CFU/ml minimum) until the best-before date, with an initial viable count of 1 × 10⁹ CFU at time of manufacture. The product is USDA Organic certified and free from synthetic additives.
Specifications
| Manufacturer | Dr. Eric Berg DC / KB Wellness LLC, USA |
|---|---|
| Format | 500 ml (16.3 fl oz) liquid; 32 servings at 15 ml per serving |
| Viable Count | 1 × 10⁹ CFU at manufacture; ≥ 4.5 × 10⁶ CFU guaranteed until best-before date |
| Probiotic Strains (12) | Lactobacillus fermentum, Bacillus subtilis, Bifidobacterium animalis, B. bifidum, B. longum, L. acidophilus, L. bulgaricus, L. casei, L. plantarum, Lactococcus lactis, Saccharomyces cerevisiae, Streptococcus thermophilus |
| Certification | USDA Organic; NSF-certified manufacturing facility; cGMP-compliant; third-party COA (heavy metals and microbials) |
| Storage | Ambient temperature; no refrigeration required; store below 30°C away from direct sunlight |
| Regulatory Status (SG) | Health supplement under HSA Health Products Act (HPA) Cap 122D; distributed by emis.asia in compliance with HSA permitted ingredient and labelling guidelines |
| Dosage | 15 ml (1 tablespoon) per day; may be mixed into water, juice, or enteral formula |
Clinical Indications and Key Applications
- Restoration and maintenance of intestinal microbiome diversity following antibiotic therapy, in alignment with the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus guidelines on probiotic use post-antibiotic disruption
- Adjunctive gastrointestinal support for patients with irritable bowel syndrome (IBS), antibiotic-associated diarrhoea, or Clostridioides difficile recurrence risk, where Lactobacillus and Bifidobacterium consortia have demonstrated evidence-based utility (Cochrane Review: Goldenberg et al., 2017)
- Paediatric and geriatric patients requiring liquid-format probiotics who cannot swallow capsules; also suitable for administration via nasogastric or PEG tube when diluted per clinical dietitian guidance
- Immune modulation support for immunocompetent patients during upper respiratory infection season, consistent with meta-analytic evidence supporting Lactobacillus strains in reducing cold duration (Hao et al., 2015)
- Home care and long-term care facility procurement requiring a shelf-stable, ambient-temperature probiotic that does not require cold chain logistics in Singapore's tropical climate
Frequently Asked Questions
Q: Why is the viable count at best-before lower than at manufacture?
Natural probiotic die-off occurs during storage even in shelf-stable formulations. The manufacturer guarantees a minimum of 4.5 × 10⁶ CFU/ml viable organisms at the best-before date — a count within the range associated with clinical benefit for gastrointestinal and immune applications based on published probiotic dose-response data.
Q: Is this product safe for immunocompromised patients?
Probiotic use in severely immunocompromised individuals (e.g., haematological malignancy, solid organ transplant recipients, those on high-dose immunosuppressants) requires clinical risk-benefit assessment. Case reports of bacteraemia and fungaemia attributable to probiotic organisms have been documented in this population. Prescribing clinicians should review current ISAPP and ESCMID guidance before recommending probiotics to immunocompromised patients.
Q: Can this product be administered via enteral feeding tube?
The liquid format makes it compatible with nasogastric and PEG tube administration when diluted appropriately. Clinical dietitians should verify compatibility with the patient's enteral formula and tube bore size. Flush the tube with water before and after administration per standard enteral protocol.
Q: Does the formula contain Saccharomyces boulardii?
The formula contains Saccharomyces cerevisiae, not S. boulardii. These are related but distinct yeast strains. S. boulardii (CNCM I-745) has the most robust randomised controlled trial evidence for antibiotic-associated diarrhoea prevention; S. cerevisiae contributes gut barrier support but is not a direct substitute in clinical protocols specifying S. boulardii.
Q: How is this product regulated in Singapore?
Sold as a health supplement under the HSA Health Products Act (HPA) Chapter 122D. Health supplements are not subject to mandatory pre-market HSA registration but must comply with permitted ingredient lists, labelling requirements, and safety provisions under the HPA Subsidiary Legislation.
Share
